市場調査レポート

商品コード

核酸医薬品の世界市場：～2029年

Global Nucleic Acid Drugs Market Insights, Forecast to 2029

出版日: 2023年11月06日 | 発行: QYResearch

| ページ情報: 英文 156 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,900 768,124円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 7,350 1,152,186円

レポートPDFを5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 9,800 1,536,248円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の核酸医薬品の市場規模は、2023年の124億8,673万米ドルから、予測期間中は3.71%のCAGRで推移し、2029年には155億3,836万米ドルの規模に成長すると予測されています。

地域別では、米国・カナダ市場は、2023年の43億5,770万米ドルから、10.46%のCAGRで推移し、2029年には79億1,760万米ドルに達すると予測されています。一方、欧州市場は、2023年の55億7,025万米ドルから、-4.24%のCAGRで推移し、2029年には42億9,509万米ドルとなると予測されています。

世界の上位5社による2022年の収益シェアは約97.87％に達しました。

当レポートでは、世界の核酸医薬品の市場を調査し、市場および製品の概要、競合情勢、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、価格動向、市場成長への各種影響因子の分析、主要企業の分析などをまとめています。

調査範囲
タイプ別市場分析
- 成長率：2018 vs 2022 vs 2029
- アンチセンスオリゴヌクレオチド (ASO) 医薬品
- 低分子干渉RNA (siRNA) 薬
- mRNA医薬品
用途別市場
- 市場シェア：2018 vs 2022 vs 2029
- 神経筋疾患
- hATTR
- COVID-19
前提・制限
調査目的
調査年数

第2章世界の成長動向

世界市場の展望
世界の成長動向：地域別
- 市場規模：2018 vs 2022 vs 2029
- 市場規模の推移
- 市場規模の予測
市場力学
- 産業動向
- 市場促進要因
- 市場課題
- 市場抑制要因

第3章競合情勢：主要企業別

収益・収益シェア：主要企業別
世界の主要企業：企業タイプ別
世界の主要企業の収益ランキング
市場集中率 (CR5)
世界の主要企業：本社およびサービス提供エリア
世界の主要企業：製品・用途
世界の主要企業：設立日
M&A・拡張計画

第4章核酸医薬品市場の内訳データ：タイプ別

市場規模の推移・予測

第5章核酸医薬品市場の内訳データ：用途別

市場規模の推移・予測

第6章北米

第7章欧州

第8章中国

第9章アジア (中国を除く)

第10章中東・アフリカ・ラテンアメリカ

第11章主要企業のプロファイル

Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Biogen
Nippon Shinyaku
Sobi
Novartis
BioNTech
Pfizer
Moderna Therapeutics
Jazz Pharmaceuticals
CureVac
Regulus Therapeutics
ProQR
Secarna
MiNA Therapeutics
Sylentis
Arrowhead
Silence Therapeutics
Dicerna

第12章アナリストによる見解・総論

第13章付録

図表

List of Tables

Table 1. Global Nucleic Acid Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Global Nucleic Acid Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 3. Global Nucleic Acid Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 4. Global Nucleic Acid Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 5. Global Nucleic Acid Drugs Market Share by Region (2018-2023)
Table 6. Global Nucleic Acid Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 7. Global Nucleic Acid Drugs Market Share by Region (2024-2029)
Table 8. Nucleic Acid Drugs Market Trends
Table 9. Nucleic Acid Drugs Market Drivers
Table 10. Nucleic Acid Drugs Market Challenges
Table 11. Nucleic Acid Drugs Market Restraints
Table 12. Global Nucleic Acid Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 13. Global Nucleic Acid Drugs Market Share by Players (2018-2023)
Table 14. Global Top Nucleic Acid Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Drugs as of 2021)
Table 15. Global Nucleic Acid Drugs Industry Ranking 2021 VS 2022
Table 16. Global 5 Largest Players Market Share by Nucleic Acid Drugs Revenue (CR5 and HHI) & (2021-2023)
Table 17. Global Key Players of Nucleic Acid Drugs, Headquarters and Area Served
Table 18. Global Key Players of Nucleic Acid Drugs, Product and Application
Table 19. Global Key Players Product Type
Table 20. Global Key Players Established Date
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Nucleic Acid Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 23. Global Nucleic Acid Drugs Revenue Market Share by Type (2018-2023)
Table 24. Global Nucleic Acid Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 25. Global Nucleic Acid Drugs Revenue Market Share by Type (2024-2029)
Table 26. Global Nucleic Acid Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 27. Global Nucleic Acid Drugs Revenue Market Share by Application (2018-2023)
Table 28. Global Nucleic Acid Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 29. Global Nucleic Acid Drugs Revenue Market Share by Application (2024-2029)
Table 30. North America Nucleic Acid Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 31. North America Nucleic Acid Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 32. North America Nucleic Acid Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 33. North America Nucleic Acid Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 34. North America Nucleic Acid Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Nucleic Acid Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Nucleic Acid Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Nucleic Acid Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 38. Europe Nucleic Acid Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 39. Europe Nucleic Acid Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 40. Europe Nucleic Acid Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 41. Europe Nucleic Acid Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Europe Nucleic Acid Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 43. Europe Nucleic Acid Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 44. China Nucleic Acid Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 45. China Nucleic Acid Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 46. China Nucleic Acid Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 47. China Nucleic Acid Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 48. Asia Nucleic Acid Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 49. Asia Nucleic Acid Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 50. Asia Nucleic Acid Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 51. Asia Nucleic Acid Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Nucleic Acid Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 53. Asia Nucleic Acid Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 54. Asia Nucleic Acid Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 55. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Nucleic Acid Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 60. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 62. Sarepta Therapeutics Company Details
Table 63. Sarepta Therapeutics Business Overview
Table 64. Sarepta Therapeutics Nucleic Acid Drugs Product
Table 65. Sarepta Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 66. Sarepta Therapeutics Recent Development
Table 67. Ionis Pharmaceuticals Company Details
Table 68. Ionis Pharmaceuticals Business Overview
Table 69. Ionis Pharmaceuticals Nucleic Acid Drugs Product
Table 70. Ionis Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 71. Ionis Pharmaceuticals Recent Development
Table 72. Alnylam Company Details
Table 73. Alnylam Business Overview
Table 74. Alnylam Nucleic Acid Drugs Product
Table 75. Alnylam Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 76. Alnylam Recent Development
Table 77. Biogen Company Details
Table 78. Biogen Business Overview
Table 79. Biogen Nucleic Acid Drugs Product
Table 80. Biogen Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 81. Biogen Recent Development
Table 82. Nippon Shinyaku Company Details
Table 83. Nippon Shinyaku Business Overview
Table 84. Nippon Shinyaku Nucleic Acid Drugs Product
Table 85. Nippon Shinyaku Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 86. Nippon Shinyaku Recent Development
Table 87. Sobi Company Details
Table 88. Sobi Business Overview
Table 89. Sobi Nucleic Acid Drugs Product
Table 90. Sobi Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 91. Sobi Recent Development
Table 92. Novartis Company Details
Table 93. Novartis Business Overview
Table 94. Novartis Nucleic Acid Drugs Product
Table 95. Novartis Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 96. Novartis Recent Development
Table 97. BioNTech Company Details
Table 98. BioNTech Business Overview
Table 99. BioNTech Nucleic Acid Drugs Product
Table 100. BioNTech Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 101. BioNTech Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Nucleic Acid Drugs Product
Table 105. Pfizer Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 106. Pfizer Recent Development
Table 107. Moderna Therapeutics Company Details
Table 108. Moderna Therapeutics Business Overview
Table 109. Moderna Therapeutics Nucleic Acid Drugs Product
Table 110. Moderna Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 111. Moderna Therapeutics Recent Development
Table 112. Jazz Pharmaceuticals Company Details
Table 113. Jazz Pharmaceuticals Business Overview
Table 114. Jazz Pharmaceuticals Nucleic Acid Drugs Product
Table 115. Jazz Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2018-2023) & (US$ Million)
Table 116. Jazz Pharmaceuticals Recent Development
Table 117. CureVac Company Details
Table 118. CureVac Business Overview
Table 119. CureVac Nucleic Acid Drugs Product
Table 120. CureVac Recent Development
Table 121. Regulus Therapeutics Company Details
Table 122. Regulus Therapeutics Business Overview
Table 123. Regulus Therapeutics Nucleic Acid Drugs Product
Table 124. Regulus Therapeutics Recent Development
Table 125. ProQR Company Details
Table 126. ProQR Business Overview
Table 127. ProQR Nucleic Acid Drugs Product
Table 128. ProQR Recent Development
Table 129. Secarna Company Details
Table 130. Secarna Business Overview
Table 131. Secarna Nucleic Acid Drugs Product
Table 132. Secarna Recent Development
Table 133. MiNA Therapeutics Company Details
Table 134. MiNA Therapeutics Business Overview
Table 135. MiNA Therapeutics Nucleic Acid Drugs Product
Table 136. MiNA Therapeutics Recent Development
Table 137. Sylentis Company Details
Table 138. Sylentis Business Overview
Table 139. Sylentis Nucleic Acid Drugs Product
Table 140. Sylentis Recent Development
Table 141. Arrowhead Company Details
Table 142. Arrowhead Business Overview
Table 143. Arrowhead Nucleic Acid Drugs Product
Table 144. Arrowhead Recent Development
Table 145. Silence Therapeutics Company Details
Table 146. Silence Therapeutics Business Overview
Table 147. Silence Therapeutics Nucleic Acid Drugs Product
Table 148. Silence Therapeutics Recent Development
Table 149. Dicerna Company Details
Table 150. Dicerna Business Overview
Table 151. Dicerna Nucleic Acid Drugs Product
Table 152. Dicerna Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Global Nucleic Acid Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Nucleic Acid Drugs Market Share by Type: 2022
Figure 3. Global Nucleic Acid Drugs Market Share by Type: 2029
Figure 4. Antisense Oligonucleotides (ASOs) Drugs Features
Figure 5. Small Interfering RNA (siRNA) Drugs Features
Figure 6. mRNA Drugs Features
Figure 7. Global Nucleic Acid Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Nucleic Acid Drugs Market Share by Application: 2022
Figure 9. Global Nucleic Acid Drugs Market Share by Application: 2029
Figure 10. Neuromuscular Diseases Case Studies
Figure 11. hATTR Case Studies
Figure 12. COVID-19 Case Studies
Figure 13. Nucleic Acid Drugs Report Years Considered
Figure 14. Global Nucleic Acid Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Nucleic Acid Drugs Market Size, (US$ Million), 2018 VS 2023 VS 2029
Figure 16. Global Nucleic Acid Drugs Market Share by Region: 2022
Figure 17. Global Nucleic Acid Drugs Market Share by Region: 2029
Figure 18. Global Nucleic Acid Drugs Market Share by Players in 2022
Figure 19. The Top 5Players Market Share by Nucleic Acid Drugs Revenue in 2022
Figure 20. North America Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Nucleic Acid Drugs Market Share by Type (2018-2029)
Figure 22. North America Nucleic Acid Drugs Market Share by Application (2018-2029)
Figure 23. North America Nucleic Acid Drugs Market Share by Country (2018-2029)
Figure 24. United States Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Nucleic Acid Drugs Market Share by Type (2018-2029)
Figure 28. Europe Nucleic Acid Drugs Market Share by Application (2018-2029)
Figure 29. Europe Nucleic Acid Drugs Market Share by Country (2018-2029)
Figure 30. Germany Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Nucleic Acid Drugs Market Share by Type (2018-2029)
Figure 37. China Nucleic Acid Drugs Market Share by Application (2018-2029)
Figure 38. Asia Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Asia Nucleic Acid Drugs Market Share by Type (2018-2029)
Figure 40. Asia Nucleic Acid Drugs Market Share by Application (2018-2029)
Figure 41. Asia Nucleic Acid Drugs Market Share by Region (2018-2029)
Figure 42. Japan Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Country (2018-2029)
Figure 51. Brazil Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Middle East Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Africa Nucleic Acid Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

The global Nucleic Acid Drugs market size is projected to reach US$ 15538.36 million by 2029, from US$ 12486.73 million in 2023, at a CAGR of 3.71% during 2023-2029

The US & Canada market for Nucleic Acid Drugs is estimated to increase from $ 4357.7 million in 2023 to reach $ 7917.6 million by 2029, at a CAGR of 10.46% during the forecast period of 2023 through 2029.

The Europe market for Nucleic Acid Drugs is estimated to increase from $ 5570.25 million in 2023 to reach $ 4295.09million by 2029, at a CAGR of -4.24% during the forecast period of 2023 through 2029.

The global key companies of Nucleic Acid Drugs include: Pfizer, Moderna Therapeutics, BioNTech, Biogen, Alnylam, Sarepta Therapeutics, Jazz Pharmaceuticals, Nippon Shinyaku, Novartis, Sobi, Ionis Pharmaceuticals, etc. In 2022, the global top five players had a share approximately 97.87% in terms of revenue.

Report Includes:

This report presents an overview of global market for Nucleic Acid Drugs market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Nucleic Acid Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Nucleic Acid Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nucleic Acid Drugsrevenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Nucleic Acid Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Nucleic Acid Drugs revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, BioNTech, Nippon Shinyaku, Moderna Therapeutics, CureVac, and Biogen, etc.

By Company

On Market Company

Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
Biogen
Nippon Shinyaku
Sobi
Novartis
BioNTech
Pfizer
Moderna Therapeutics
Jazz Pharmaceuticals

On Pipeline Company

CureVac
Regulus Therapeutics
ProQR
Secarna
MiNA Therapeutics
Sylentis
Arrowhead
Silence Therapeutics
Dicerna

Segment by Type

Antisense Oligonucleotides (ASOs) Drugs
Small Interfering RNA (siRNA) Drugs
mRNA Drugs
Others

Segment by Application

Neuromuscular Diseases
hATTR
COVID-19
Other

By Region

North America
- United States
- Canada
- China

Asia-Pacific
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia

Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Rest of Europe

Latin America, Middle East & Africa
- Mexico
- Brazil
- Rest of Latin America
- Middle East
- Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Nucleic Acid Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nucleic Acid Drugs companies's competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, revenue for each segment.

Chapter 8: China by Type, and by Application, revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nucleic Acid Drugsrevenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions.

1 Report Overview

1.1 Study Scope
1.2 Market Analysis by Type
- 1.2.1 Global Nucleic Acid Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
- 1.2.2 Antisense Oligonucleotides (ASOs) Drugs
- 1.2.3 Small Interfering RNA (siRNA) Drugs
- 1.2.4 mRNA Drugs
1.3 Market by Application
- 1.3.1 Global Nucleic Acid Drugs Market Share by Application: 2018 VS 2022 VS 2029
- 1.3.2 Neuromuscular Diseases
- 1.3.3 hATTR
- 1.3.4 COVID-19
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends

2.1 Global Nucleic Acid Drugs Market Perspective (2018-2029)
2.2 Global Nucleic Acid Drugs Growth Trends by Region
- 2.2.1 Global Nucleic Acid Drugs Market Size by Region: 2018 VS 2022 VS 2029
- 2.2.2 Nucleic Acid Drugs Historic Market Size by Region (2018-2023)
- 2.2.3 Nucleic Acid Drugs Forecasted Market Size by Region (2024-2029)
2.3 Nucleic Acid Drugs Market Dynamics
- 2.3.1 Nucleic Acid Drugs Industry Trends
- 2.3.2 Nucleic Acid Drugs Market Drivers
- 2.3.3 Nucleic Acid Drugs Market Challenges
- 2.3.4 Nucleic Acid Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Nucleic Acid Drugs by Players
- 3.1.1 Global Nucleic Acid Drugs Revenue by Players (2018-2023)
- 3.1.2 Global Nucleic Acid Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Nucleic Acid Drugs Market by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Nucleic Acid Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Nucleic Acid Drugs Market Concentration Ratio
- 3.4.1 Global Nucleic Acid Drugs Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 5 Companies by Nucleic Acid Drugs Revenue in 2022
3.5 Global Key Players of Nucleic Acid Drugs Head office and Area Served
3.6 Global Key Players of Nucleic Acid Drugs, Product and Application
3.7 Global Key Players Established Date
3.8 Mergers & Acquisitions, Expansion Plans

4 Nucleic Acid Drugs Breakdown Data by Type

4.1 Global Nucleic Acid Drugs Historic Market Size by Type (2018-2023)
4.2 Global Nucleic Acid Drugs Forecasted Market Size by Type (2024-2029)

5 Nucleic Acid Drugs Breakdown Data by Application

5.1 Global Nucleic Acid Drugs Historic Market Size by Application (2018-2023)
5.2 Global Nucleic Acid Drugs Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Nucleic Acid Drugs Market Size (2018-2029)
6.2 North America Nucleic Acid Drugs Market Size by Type
- 6.2.1 North America Nucleic Acid Drugs Market Size by Type (2018-2023)
- 6.2.2 North America Nucleic Acid Drugs Market Size by Type (2024-2029)
- 6.2.3 North America Nucleic Acid Drugs Market Share by Type (2018-2029)
6.3 North America Nucleic Acid Drugs Market Size by Application
- 6.3.1 North America Nucleic Acid Drugs Market Size by Application (2018-2023)
- 6.3.2 North America Nucleic Acid Drugs Market Size by Application (2024-2029)
- 6.3.3 North America Nucleic Acid Drugs Market Share by Application (2018-2029)
6.4 North America Nucleic Acid Drugs Market Size by Country
- 6.4.1 North America Nucleic Acid Drugs Market Size by Country: 2018 VS 2022 VS 2029
- 6.4.2 North America Nucleic Acid Drugs Market Size by Country (2018-2023)
- 6.4.3 North America Nucleic Acid Drugs Market Share by Country (2024-2029)
- 6.4.4 United States
- 6.4.5 Canada

7 Europe

7.1 Europe Nucleic Acid Drugs Market Size (2018-2029)
7.2 Europe Nucleic Acid Drugs Market Size by Type
- 7.2.1 Europe Nucleic Acid Drugs Market Size by Type (2018-2023)
- 7.2.2 Europe Nucleic Acid Drugs Market Size by Type (2024-2029)
- 7.2.3 Europe Nucleic Acid Drugs Market Share by Type (2018-2029)
7.3 Europe Nucleic Acid Drugs Market Size by Application
- 7.3.1 Europe Nucleic Acid Drugs Market Size by Application (2018-2023)
- 7.3.2 Europe Nucleic Acid Drugs Market Size by Application (2024-2029)
- 7.3.3 Europe Nucleic Acid Drugs Market Share by Application (2018-2029)
7.4 Europe Nucleic Acid Drugs Market Size by Country
- 7.4.1 Europe Nucleic Acid Drugs Market Size by Country: 2018 VS 2022 VS 2029
- 7.4.2 Europe Nucleic Acid Drugs Market Size by Country (2018-2023)
- 7.4.3 Europe Nucleic Acid Drugs Market Size by Country (2024-2029)
- 7.4.4 Germany
- 7.4.5 France
- 7.4.6 U.K.
- 7.4.7 Italy
- 7.4.8 Russia

8 China

8.1 China Nucleic Acid Drugs Market Size (2018-2029)
8.2 China Nucleic Acid Drugs Market Size by Type
- 8.2.1 China Nucleic Acid Drugs Market Size by Type (2018-2023)
- 8.2.2 China Nucleic Acid Drugs Market Size by Type (2024-2029)
- 8.2.3 China Nucleic Acid Drugs Market Share by Type (2018-2029)
8.3 China Nucleic Acid Drugs Market Size by Application
- 8.3.1 China Nucleic Acid Drugs Market Size by Application (2018-2023)
- 8.3.2 China Nucleic Acid Drugs Market Size by Application (2024-2029)
- 8.3.3 China Nucleic Acid Drugs Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Nucleic Acid Drugs Market Size (2018-2029)
9.2 Asia Nucleic Acid Drugs Market Size by Type
- 9.2.1 Asia Nucleic Acid Drugs Market Size by Type (2018-2023)
- 9.2.2 Asia Nucleic Acid Drugs Market Size by Type (2024-2029)
- 9.2.3 Asia Nucleic Acid Drugs Market Share by Type (2018-2029)
9.3 Asia Nucleic Acid Drugs Market Size by Application
- 9.3.1 Asia Nucleic Acid Drugs Market Size by Application (2018-2023)
- 9.3.2 Asia Nucleic Acid Drugs Market Size by Application (2024-2029)
- 9.3.3 Asia Nucleic Acid Drugs Market Share by Application (2018-2029)
9.4 Asia Nucleic Acid Drugs Market Size by Region
- 9.4.1 Asia Nucleic Acid Drugs Market Size by Region: 2018 VS 2022 VS 2029
- 9.4.2 Asia Nucleic Acid Drugs Market Size by Region (2018-2023)
- 9.4.3 Asia Nucleic Acid Drugs Market Size by Region (2024-2029)
- 9.4.4 Japan
- 9.4.5 South Korea
- 9.4.6 Southeast Asia
- 9.4.7 India
- 9.4.8 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Type
- 10.2.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Type (2018-2023)
- 10.2.2 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Type (2024-2029)
- 10.2.3 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Application
- 10.3.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Application (2018-2023)
- 10.3.2 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Application (2024-2029)
- 10.3.3 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country
- 10.4.1 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country: 2018 VS 2022 VS 2029
- 10.4.2 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country (2018-2023)
- 10.4.3 Middle East, Africa, and Latin America Nucleic Acid Drugs Market Size by Country (2024-2029)
- 10.4.4 Brazil
- 10.4.5 Mexico
- 10.4.6 Middle East
- 10.4.7 Africa

11 Key Players Profiles

11.1 Sarepta Therapeutics
- 11.1.1 Sarepta Therapeutics Company Details
- 11.1.2 Sarepta Therapeutics Business Overview
- 11.1.3 Sarepta Therapeutics Nucleic Acid Drugs Introduction
- 11.1.4 Sarepta Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023)
- 11.1.5 Sarepta Therapeutics Recent Development
11.2 Ionis Pharmaceuticals
- 11.2.1 Ionis Pharmaceuticals Company Details
- 11.2.2 Ionis Pharmaceuticals Business Overview
- 11.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Introduction
- 11.2.4 Ionis Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2018-2023)
- 11.2.5 Ionis Pharmaceuticals Recent Development
11.3 Alnylam
- 11.3.1 Alnylam Company Details
- 11.3.2 Alnylam Business Overview
- 11.3.3 Alnylam Nucleic Acid Drugs Introduction
- 11.3.4 Alnylam Revenue in Nucleic Acid Drugs Business (2018-2023)
- 11.3.5 Alnylam Recent Development
11.4 Biogen
- 11.4.1 Biogen Company Details
- 11.4.2 Biogen Business Overview
- 11.4.3 Biogen Nucleic Acid Drugs Introduction
- 11.4.4 Biogen Revenue in Nucleic Acid Drugs Business (2018-2023)
- 11.4.5 Biogen Recent Development
11.5 Nippon Shinyaku
- 11.5.1 Nippon Shinyaku Company Details
- 11.5.2 Nippon Shinyaku Business Overview
- 11.5.3 Nippon Shinyaku Nucleic Acid Drugs Introduction
- 11.5.4 Nippon Shinyaku Revenue in Nucleic Acid Drugs Business (2018-2023)
- 11.5.5 Nippon Shinyaku Recent Development
11.6 Sobi
- 11.6.1 Sobi Company Details
- 11.6.2 Sobi Business Overview
- 11.6.3 Sobi Nucleic Acid Drugs Introduction
- 11.6.4 Sobi Revenue in Nucleic Acid Drugs Business (2018-2023)
- 11.6.5 Sobi Recent Development
11.7 Novartis
- 11.7.1 Novartis Company Details
- 11.7.2 Novartis Business Overview
- 11.7.3 Novartis Nucleic Acid Drugs Introduction
- 11.7.4 Novartis Revenue in Nucleic Acid Drugs Business (2018-2023)
- 11.7.5 Novartis Recent Development
11.8 BioNTech
- 11.8.1 BioNTech Company Details
- 11.8.2 BioNTech Business Overview
- 11.8.3 BioNTech Nucleic Acid Drugs Introduction
- 11.8.4 BioNTech Revenue in Nucleic Acid Drugs Business (2018-2023)
- 11.8.5 BioNTech Recent Development
11.9 Pfizer
- 11.9.1 Pfizer Company Details
- 11.9.2 Pfizer Business Overview
- 11.9.3 Pfizer Nucleic Acid Drugs Introduction
- 11.9.4 Pfizer Revenue in Nucleic Acid Drugs Business (2018-2023)
- 11.9.5 Pfizer Recent Development
11.10 Moderna Therapeutics
- 11.10.1 Moderna Therapeutics Company Details
- 11.10.2 Moderna Therapeutics Business Overview
- 11.10.3 Moderna Therapeutics Nucleic Acid Drugs Introduction
- 11.10.4 Moderna Therapeutics Revenue in Nucleic Acid Drugs Business (2018-2023)
- 11.10.5 Moderna Therapeutics Recent Development
11.11 Jazz Pharmaceuticals
- 11.11.1 Jazz Pharmaceuticals Company Details
- 11.11.2 Jazz Pharmaceuticals Business Overview
- 11.11.3 Jazz Pharmaceuticals Nucleic Acid Drugs Introduction
- 11.11.4 Jazz Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2018-2023)
- 11.11.5 Jazz Pharmaceuticals Recent Development
11.12 CureVac
- 11.12.1 CureVac Company Details
- 11.12.2 CureVac Business Overview
- 11.12.3 CureVac Nucleic Acid Drugs Introduction
- 11.12.4 CureVac Recent Development
11.13 Regulus Therapeutics
- 11.13.1 Regulus Therapeutics Company Details
- 11.13.2 Regulus Therapeutics Business Overview
- 11.13.3 Regulus Therapeutics Nucleic Acid Drugs Introduction
- 11.13.4 Regulus Therapeutics Recent Development
11.14 ProQR
- 11.14.1 ProQR Company Details
- 11.14.2 ProQR Business Overview
- 11.14.3 ProQR Nucleic Acid Drugs Introduction
- 11.14.4 ProQR Recent Development
11.15 Secarna
- 11.15.1 Secarna Company Details
- 11.15.2 Secarna Business Overview
- 11.15.3 Secarna Nucleic Acid Drugs Introduction
- 11.15.4 Secarna Recent Development
11.16 MiNA Therapeutics
- 11.16.1 MiNA Therapeutics Company Details
- 11.16.2 MiNA Therapeutics Business Overview
- 11.16.3 MiNA Therapeutics Nucleic Acid Drugs Introduction
- 11.16.4 MiNA Therapeutics Recent Development
11.17 Sylentis
- 11.17.1 Sylentis Company Details
- 11.17.2 Sylentis Business Overview
- 11.17.3 Sylentis Nucleic Acid Drugs Introduction
- 11.17.4 Sylentis Recent Development
11.18 Arrowhead
- 11.18.1 Arrowhead Company Details
- 11.18.2 Arrowhead Business Overview
- 11.18.3 Arrowhead Nucleic Acid Drugs Introduction
- 11.18.4 Arrowhead Recent Development
11.19 Silence Therapeutics
- 11.19.1 Silence Therapeutics Company Details
- 11.19.2 Silence Therapeutics Business Overview
- 11.19.3 Silence Therapeutics Nucleic Acid Drugs Introduction
- 11.19.4 Silence Therapeutics Recent Development
11.20 Dicerna
- 11.20.1 Dicerna Company Details
- 11.20.2 Dicerna Business Overview
- 11.20.3 Dicerna Nucleic Acid Drugs Introduction
- 11.20.4 Dicerna Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

核酸医薬品の世界市場：～2029年

Global Nucleic Acid Drugs Market Insights, Forecast to 2029

目次

第1章レポート概要

第2章世界の成長動向

第3章競合情勢：主要企業別

第4章核酸医薬品市場の内訳データ：タイプ別

第5章核酸医薬品市場の内訳データ：用途別

第6章北米

第7章欧州

第8章中国

第9章アジア (中国を除く)

第10章中東・アフリカ・ラテンアメリカ

第11章主要企業のプロファイル

第12章アナリストによる見解・総論

第13章付録

List of Tables

List of Figures

Report Includes:

By Company

On Market Company

On Pipeline Company

Segment by Type

Segment by Application

By Region

Chapter Outline

Table of Contents

1 Report Overview

2 Global Growth Trends

3 Competition Landscape by Key Players

4 Nucleic Acid Drugs Breakdown Data by Type

5 Nucleic Acid Drugs Breakdown Data by Application

6 North America

7 Europe

8 China

9 Asia (excluding China)

10 Middle East, Africa, and Latin America

11 Key Players Profiles

12 Analyst's Viewpoints/Conclusions

13 Appendix

核酸医薬品の世界市場：～2029年

Global Nucleic Acid Drugs Market Insights, Forecast to 2029

目次

第1章 レポート概要

第2章 世界の成長動向

第3章 競合情勢：主要企業別

第4章 核酸医薬品市場の内訳データ：タイプ別

第5章 核酸医薬品市場の内訳データ：用途別

第6章 北米

第7章 欧州

第8章 中国

第9章 アジア (中国を除く)

第10章 中東・アフリカ・ラテンアメリカ

第11章 主要企業のプロファイル

第12章 アナリストによる見解・総論

第13章 付録

List of Tables

List of Figures

Report Includes:

By Company

On Market Company

On Pipeline Company

Segment by Type

Segment by Application

By Region

Chapter Outline

Table of Contents

1 Report Overview

2 Global Growth Trends

3 Competition Landscape by Key Players

4 Nucleic Acid Drugs Breakdown Data by Type

5 Nucleic Acid Drugs Breakdown Data by Application

6 North America

7 Europe

8 China

9 Asia (excluding China)

10 Middle East, Africa, and Latin America

11 Key Players Profiles

12 Analyst's Viewpoints/Conclusions

13 Appendix

第1章レポート概要

第2章世界の成長動向

第3章競合情勢：主要企業別

第4章核酸医薬品市場の内訳データ：タイプ別

第5章核酸医薬品市場の内訳データ：用途別

第6章北米

第7章欧州

第8章中国

第9章アジア (中国を除く)

第10章中東・アフリカ・ラテンアメリカ

第11章主要企業のプロファイル

第12章アナリストによる見解・総論

第13章付録